An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging.

The immune response is essential for survival by destroying microorganisms and pre-cancerous cells. However, inflammation, one aspect of this response, can result in short- and long-term deleterious side-effects. Mclk1⁺/⁻ mutant mice can be long-lived despite displaying a hair-trigger inflammatory r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dantong Wang, Ying Wang, Catherine Argyriou, Audrey Carrière, Danielle Malo, Siegfried Hekimi
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c4a37b066ebf4341844796b2c386072b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c4a37b066ebf4341844796b2c386072b
record_format dspace
spelling oai:doaj.org-article:c4a37b066ebf4341844796b2c386072b2021-11-18T08:08:41ZAn enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging.1932-620310.1371/journal.pone.0049606https://doaj.org/article/c4a37b066ebf4341844796b2c386072b2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23166727/?tool=EBIhttps://doaj.org/toc/1932-6203The immune response is essential for survival by destroying microorganisms and pre-cancerous cells. However, inflammation, one aspect of this response, can result in short- and long-term deleterious side-effects. Mclk1⁺/⁻ mutant mice can be long-lived despite displaying a hair-trigger inflammatory response and chronically activated macrophages as a result of high mitochondrial ROS generation. Here we ask whether this phenotype is beneficial or simply tolerated. We used models of infection by Salmonella serovars and found that Mclk1⁺/⁻ mutants mount a stronger immune response, control bacterial proliferation better, and are resistant to cell and tissue damage resulting from the response, including fibrosis and types of oxidative damage that are considered to be biomarkers of aging. Moreover, these same types of tissue damage were found to be low in untreated 23 months-old mutants. We also examined the initiation of tumour growth after transplantation of mouse LLC1 carcinoma cells into Mclk1⁺/⁻ mutants, as well as during spontaneous tumorigenesis in Mclk1⁺/⁻Trp53⁺/⁻ double mutants. Tumour latency was increased by the Mclk1⁺/⁻ genotype in both models. Furthermore, we used the transplantation model to show that splenic CD8⁺ T lymphocytes from Mclk1⁺/⁻ graft recipients show enhanced cytotoxicity against LLC1 cells in vitro. Mclk1⁺/⁻ mutants thus display an association of an enhanced immune response with partial protection from age-dependent processes and from pathologies similar to those that are found with increased frequency during the aging process. This suggests that the immune phenotype of these mutants might contribute to their longevity. We discuss how these findings suggest a broader view of how the immune response might impact the aging process.Dantong WangYing WangCatherine ArgyriouAudrey CarrièreDanielle MaloSiegfried HekimiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 11, p e49606 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Dantong Wang
Ying Wang
Catherine Argyriou
Audrey Carrière
Danielle Malo
Siegfried Hekimi
An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging.
description The immune response is essential for survival by destroying microorganisms and pre-cancerous cells. However, inflammation, one aspect of this response, can result in short- and long-term deleterious side-effects. Mclk1⁺/⁻ mutant mice can be long-lived despite displaying a hair-trigger inflammatory response and chronically activated macrophages as a result of high mitochondrial ROS generation. Here we ask whether this phenotype is beneficial or simply tolerated. We used models of infection by Salmonella serovars and found that Mclk1⁺/⁻ mutants mount a stronger immune response, control bacterial proliferation better, and are resistant to cell and tissue damage resulting from the response, including fibrosis and types of oxidative damage that are considered to be biomarkers of aging. Moreover, these same types of tissue damage were found to be low in untreated 23 months-old mutants. We also examined the initiation of tumour growth after transplantation of mouse LLC1 carcinoma cells into Mclk1⁺/⁻ mutants, as well as during spontaneous tumorigenesis in Mclk1⁺/⁻Trp53⁺/⁻ double mutants. Tumour latency was increased by the Mclk1⁺/⁻ genotype in both models. Furthermore, we used the transplantation model to show that splenic CD8⁺ T lymphocytes from Mclk1⁺/⁻ graft recipients show enhanced cytotoxicity against LLC1 cells in vitro. Mclk1⁺/⁻ mutants thus display an association of an enhanced immune response with partial protection from age-dependent processes and from pathologies similar to those that are found with increased frequency during the aging process. This suggests that the immune phenotype of these mutants might contribute to their longevity. We discuss how these findings suggest a broader view of how the immune response might impact the aging process.
format article
author Dantong Wang
Ying Wang
Catherine Argyriou
Audrey Carrière
Danielle Malo
Siegfried Hekimi
author_facet Dantong Wang
Ying Wang
Catherine Argyriou
Audrey Carrière
Danielle Malo
Siegfried Hekimi
author_sort Dantong Wang
title An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging.
title_short An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging.
title_full An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging.
title_fullStr An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging.
title_full_unstemmed An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging.
title_sort enhanced immune response of mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/c4a37b066ebf4341844796b2c386072b
work_keys_str_mv AT dantongwang anenhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT yingwang anenhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT catherineargyriou anenhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT audreycarriere anenhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT daniellemalo anenhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT siegfriedhekimi anenhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT dantongwang enhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT yingwang enhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT catherineargyriou enhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT audreycarriere enhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT daniellemalo enhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
AT siegfriedhekimi enhancedimmuneresponseofmclk1mutantmiceisassociatedwithpartialprotectionfromfibrosiscancerandthedevelopmentofbiomarkersofaging
_version_ 1718422193287725056